Evidence map›Paper›PMID 39219501›Full record

ArticleHaematologica2025

T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas.

Edith Willscher, Christoph Schultheiß, Lisa Paschold, Franziska Lea Schümann, Paul Schmidt-Barbo, Benjamin Thiele, Marcus Bauer, Claudia Wickenhauser, Thomas Weber, Mascha Binder

Abstract read
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. IGLV3-21Haematologica · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Edith WillscherInternal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle.
Christoph SchultheißDepartment of Biomedicine, Translational Immuno-Oncology, University of Basel, Basel, Switzerland; Division of Medical Oncology, University Hospital Basel, Basel.
Lisa PascholdInternal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle.
Franziska Lea SchümannInternal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle.
Paul Schmidt-BarboDepartment of Biomedicine, Translational Immuno-Oncology, University of Basel, Basel.
Benjamin ThieleDepartment of Biomedicine, Translational Immuno-Oncology, University of Basel, Basel, Switzerland; Division of Medical Oncology, University Hospital Basel, Basel.
Marcus BauerDepartment of Pathology, Martin-Luther-University Halle-Wittenberg, Halle.
Claudia WickenhauserDepartment of Pathology, Martin-Luther-University Halle-Wittenberg, Halle.
Thomas WeberInternal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle.
Mascha BinderDepartment of Biomedicine, Translational Immuno-Oncology, University of Basel, Basel, Switzerland; Division of Medical Oncology, University Hospital Basel, Basel. mascha.binder@usb.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While T-cell lymphomas are classified as mature neoplasms, emerging evidence indicates that malignant transformation may occur at an earlier stage of T-cell maturation. In this study, we determined clonal architecture in a broad range of T-cell lymphomas. Our multidimensional profiling indicates that many of these lymphomas do in fact emerge from an immature lymphoid T-cell precursor at a maturation stage prior to V(D)J rearrangement that undergoes branching evolution. Consequently, at single-cell resolution we observed considerable clonal tiding under selective therapeutic pressure. T-cell receptor next-generation sequencing suggested a highly biased usage of TRBV20-1 gene segments as part of multiple antigen receptor rearrangements per patient. The predominance of TRBV20-1 was found across all major T-cell lymphoma subtypes analyzed. This suggested that this particular V gene - independently of complementarity-determining region 3 configuration - may represent a driver of malignant transformation. Together, our data indicate that T-cell lymphomas are derived from immature lymphoid precursors and display considerable intratumoral heterogeneity that may provide the basis for relapse and resistance in these hard-to-treat cancers.

Indexed as

Cell Transformation, NeoplasticClonal EvolutionLymphoma, T-Cell, PeripheralReceptors, Antigen, T-CellHigh-Throughput Nucleotide SequencingHumansReceptors, Antigen, T-Cell

Identifiers

PMID39219501
PMCPMC11788643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.